Back to ACAD
Hennion & Walsh Asset Management, Inc. → ACAD
Hennion & Walsh Asset Management, Inc. ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
5
Latest value
$1.9M
Q3 2026
Peak value
$2.8M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $2.8M |
| Q4 2025 | $2.8M |
| Q1 2026 | $2.2M |
| Q2 2026 | $2.6M |
| Q3 2026 | $1.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.9M | 95.9K | — | — |
| Q2 2026 | $2.6M | 103.3K | — | — |
| Q1 2026 | $2.2M | 100.7K | — | — |
| Q4 2025 | $2.8M | 103.8K | — | — |
| Q3 2025 | $2.8M | 131.7K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M
$211.3M
$202.4M